Cargando...
Aortic dissection in a patient treated with anlotinib for metastatic lung squamous cell carcinoma
Anlotinib is an anti‐angiogenic drug that targets vascular endothelial growth factor receptor, platelet‐derived growth factor receptor, fibroblast growth factor receptor, c‐Kit, and other kinases and has been approved for the treatment of advanced non‐small cell lung cancer (NSCLC). As in other smal...
Gardado en:
| Publicado en: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996977/ https://ncbi.nlm.nih.gov/pubmed/31891239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13288 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|